Brief: Tianjin Development Says Tianjin Lisheng Pharma's 9-Mth Net Profit Rmb36.2 Mln
25/10/2018 05:12
Oct 25 (Reuters) - Tianjin Development Holdings Ltd
0882.HK :
* TIANJIN LISHENG PHARMA'S 9-MONTH NET PROFIT RMB36.2
MILLION
Source text for Eikon: ID:nHKS6mLpfw
Further company coverage: 0882.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Development Holdings
See all newsHong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales
Brief: Tianjin Development Says Teng Fei Resigns As Chairman And Executive Director
Brief: Tianjin Development Says H1 2026 Net Profit Seen At RMB 73-83 Million For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To Investment Products Totaling RMB180 Million
Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln